方舟生物医药 (abio.o)

+ 收藏

财务摘要(报告期)(方舟生物医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
每股指标:
 每股收益EPS基本(元) -0.14-0.37-0.29-0.20-0.09-0.69-0.61-0.45-0.23
 每股净资产(元) 2.422.552.632.722.812.892.973.123.33
 每股经营现金净流量(元) -0.11-0.35-0.27-0.16-0.11-0.76-0.65-0.48-0.30
 每股现金流量净额(元) -0.11-0.35-0.27-0.16-0.11-0.76-0.65-0.48-0.30
盈利能力:
 净资产收益率平均(%) -5.57-13.57-10.67-6.99-3.27-21.41-18.67-13.37-6.61
 总资产净利率(%) -5.39-13.19-10.33-6.72-3.16-20.26-17.52-12.46-6.18
 投入资本回报率ROIC(%) -325.87-997.94-635.75-360.69-145.59-900.32-675.57-397.58-185.91
收益质量:
 营业利润/利润总额(%) 123.54136.65134.26133.37133.43106.75103.38101.20100.15
资本结构:
 资产负债率(%) 4.312.223.104.493.633.284.986.526.03
 权益乘数 1.051.021.031.051.041.031.051.071.06
 产权比率 0.050.020.030.050.040.030.050.070.06
 流动资产/总资产(%) 99.9099.2999.2599.2099.1599.1099.0899.0799.07
 非流动资产/总资产(%) 0.100.710.750.800.850.900.920.930.93
 流动负债/负债合计(%) 100.0075.7481.5886.8382.8580.1786.5589.5288.39
 非流动负债/负债合计(%) -24.2618.4213.1717.1519.8313.4510.4811.61
 归属母公司股东的权益/投入资本(%) 4,374.228,609.305,447.354,232.793,352.446,511.414,164.422,702.102,452.07
偿债能力:
 流动比率 23.1959.0139.2125.4432.9437.7223.0016.9718.59
 速动比率 23.1959.0139.2125.4432.9437.7223.0016.9718.59
 货币资金/流动负债(%) 2,270.905,876.143,879.742,506.623,226.703,749.562,268.401,653.151,804.30
 营业利润/流动负债(%) -156.99-1,145.37-575.20-235.27-141.86-936.04-467.11-231.26-120.52
 经营活动产生的现金流量净额/流动负债(%) -96.65-787.13-398.99-142.88-125.99-963.96-486.22-246.35-158.07
 归属母公司股东的权益/负债合计(%) 2,221.704,401.903,122.372,126.722,652.552,951.351,909.161,432.861,558.45
 经营活动产生的现金流量净额/负债合计(%) -96.65-596.20-325.49-124.07-104.38-772.80-420.82-220.52-139.73
 营业利润/负债合计(%) -156.99-867.54-469.24-204.28-117.54-750.42-404.29-207.01-106.53
成长能力:
 总资产同比增长率(%) -12.73-12.12-12.86-14.59-17.55-21.56-25.30-26.38-26.26
 每股净资产同比增长率(%) -13.88-11.72-11.14-12.73-15.45-18.36-24.51-26.54-27.27
 总负债同比增长率(%) 3.47-40.44-45.67-41.20-50.33-63.62-37.69-24.02-6.05
 基本每股收益同比增长率(%) -55.5646.3852.4655.5660.8750.3638.3832.8430.30
 归属母公司股东的权益同比增长率(%) -13.34-11.17-11.14-12.73-15.45-18.36-24.51-26.54-27.27
 营业利润同比增长率(%) -38.2031.1436.9441.9845.1945.2033.7427.3320.11
 股东权益合计同比增长率(%) -13.34-11.17-11.14-12.73-15.45-18.36-24.51-26.54-27.27
营运能力:
衍生指标:
 现金及现金等价物净增加额TTM(元) -4,947,000.00-5,014,000.00-5,452,000.00-6,281,000.00-8,209,000.00-10,914,000.00-14,374,000.00-16,760,000.00-17,874,000.00
 利润总额TTM(元) -6,002,000.00-5,339,000.00-5,424,000.00-6,333,000.00-8,000,000.00-9,926,000.00-14,428,000.00-16,807,000.00-18,494,000.00
 投入资本(元) 803,000.00430,000.00697,000.00927,000.001,209,000.00640,000.001,026,000.001,664,000.001,955,000.00
 经营活动产生的现金流量净额TTM(元) -4,947,000.00-5,014,000.00-5,452,000.00-6,281,000.00-8,209,000.00-10,912,000.00-14,365,000.00-16,737,000.00-17,835,000.00
 归属母公司净利润TTM(元) -6,002,000.00-5,339,000.00-5,424,000.00-6,333,000.00-8,000,000.00-9,926,000.00-14,428,000.00-16,807,000.00-18,494,000.00

前瞻产业研究院